Stock listing

NASDAQ:PATH NuPathe Inc. Stock

Follow NuPathe Inc. into a list and get an email when it puts out news.

Last close · NASDAQ:PATH

$4.25 USD

Close on Feb 21, 2014 · No longer trades

Aug 6, 2010 to last close -55.8% · weekly closes, Aug 6, 2010 – Feb 21, 2014
Lowest – highest close
$1.60 – $9.61 USDSince Aug 6, 2010 · lowest Dec 21, 2011 · highest Aug 6, 2010

Delisted NASDAQ:PATH no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:PATH
Asset type
Stock
Exchange
NASDAQ
Currency
USD

NuPathe Inc. on 6ix

Decks
6 decks · latest Sep 11, 2013

Events

Next results
Dec 3, 2026 (expected)
QuarterResultsShare move
Quarter to Jul 31, 2026Sep 3, 2026 · After close−16.6%
Quarter to Apr 30, 2026May 28, 2026 · After close+1.2%
Quarter to Jan 31, 2026Mar 11, 2026 · After close−8.2%
Quarter to Oct 31, 2025Dec 3, 2025 · After close+24.4%
Quarter to Jul 31, 2025Sep 4, 2025 · After close+5.9%
Quarter to Apr 30, 2025May 29, 2025 · After close+2.9%
Quarter to Jan 31, 2025Mar 12, 2025 · After close−15.7%
Quarter to Oct 31, 2024Dec 5, 2024 · After close−0.9%
Quarter to Jul 31, 2024Sep 5, 2024 · After close−6.0%
Quarter to Apr 30, 2024May 29, 2024 · After close−34.0%
All 20 quarters
QuarterResultsShare move
Quarter to Jan 31, 2024Mar 13, 2024 · After close−6.9%
Quarter to Oct 31, 2023Nov 30, 2023 · After close+26.7%
Quarter to Jul 31, 2023Sep 5, 2023 · After close+0.3%
Quarter to Apr 30, 2023May 24, 2023 · After close−11.2%
Quarter to Jan 31, 2023Mar 15, 2023 · After close+17.6%
Quarter to Oct 31, 2022Dec 1, 2022 · After close+12.5%
Quarter to Jul 31, 2022Sep 6, 2022 · After close−11.2%
Quarter to Apr 30, 2022Jun 1, 2022 · After close+16.7%
Quarter to Jan 31, 2022Mar 30, 2022 · After close−25.6%
Quarter to Oct 31, 2021Dec 8, 2021 · After close−1.4%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (September 2013)Investor deck32 slidesSep 11, 2013
Investor Presentation (November 2012)Investor deck20 slidesNov 13, 2012
Investor Presentation (October 2012)Investor deck19 slidesOct 9, 2012
Investor Presentation (October 2011)Investor deck21 slidesOct 3, 2011
JP Morgan Healthcare Conference January 2011Conference21 slidesJan 10, 2011
Stifel Nicolaus 2010 Healthcare ConferenceConference21 slidesSep 16, 2010

Open Decks

Cap table

Built by 6ix from NuPathe Inc.’s releases

Common shares
456,464,703
Fully diluted
456,464,703

Fully diluted

LineShares
Common shares456,464,703

Share count over time

CountShares
Nov 22, 2026456,464,703

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Armando Anido
Other companies: Scynexis, Inc. (Director · Since at least Jan 21, 2019); Vaxart, Inc. (Director · Sep 21, 2015 – May 18, 2017 · Past); Zynerba Pharmaceuticals Inc (Chairman & Chief Exec. Officer, Director · Aug 4, 2015 – Oct 10, 2023 · Past); Adolor Corp (Director · May 18, 2010 – Dec 7, 2011 · Past); Auxilium Pharmaceuticals Inc (CEO & President, Director · Apr 12, 2010 – Oct 7, 2011 · Past)
Chief Executive Officer, Director · Jul 25, 2012 – Feb 21, 2014 · Past
Michael Cola
Other companies: Phathom Pharmaceuticals, Inc. (Director · Since at least Oct 24, 2019); Sage Therapeutics Inc (Director · Since at least Sep 11, 2014); Avalo Therapeutics, Inc. (Chief Executive Officer, Director · Feb 3, 2020 – Oct 1, 2021 · Past); Aevi Genomic Medicine LLC (Chief Executive Officer, Director · Sep 13, 2013 – Jun 9, 2020 · Past); Vanda Pharmaceuticals Inc. (Director · Jun 14, 2012 – Jun 13, 2019 · Past)
Director · Sep 30, 2011 – Feb 21, 2014 · Past
William J Federici
Other companies: Stevanato Group S.p.A. (Director · Since at least Mar 18, 2026); Zynerba Pharmaceuticals Inc (Director · Aug 4, 2015 – Oct 10, 2023 · Past); West Pharmaceutical Services, Inc. (Sr. VP & CFO · Dec 30, 2005 – Jun 8, 2018 · Past)
Director · Jan 5, 2011 – Feb 21, 2014 · Past
Bart J DunnVP, Corp Dev & Licensing · Nov 1, 2011 – Nov 1, 2011 · Past

Open People

Log in to ask 6ix AI your own questions about NuPathe Inc.